Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | EGBN | HAFC |
|---|---|---|
| Price | $28.03 | $31.38 |
| Change today | ▼ 0.74% | ▼ 0.95% |
| Market cap | $854.47M | $930.39M |
| Return, 3 months | +4.5% | -0.9% |
| Return, year to date | +31.0% | +19.4% |
| Return, 1 year | +34.0% | +32.3% |
| P/E (TTM) | -17.6 | 10.6 |
| P/B | 0.7 | 1.1 |
| P/E percentile vs own 5y | 13th | 66th |
| Dividend yield | 0.70% | 3.51% |
| Revenue growth (YoY, latest qtr) | -1.5% | +10.7% |
| Net profit growth (YoY) | +109.9% | +55.5% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | -16.1% | 31.0% |
| Return on equity | -4.1% | 11.3% |
| Analyst target vs. price | +12.4% | +10.5% |
| Analyst buy share | 50% | 33% |
| RSI (14) | 49 | 46 |
| 30-day volatility | 18.0% | 14.9% |
| Max drawdown, 1 year | -26.6% | -16.2% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
